Want to join the conversation?
$ECL remains focused on driving growth and outperforming end markets through continued focus on product innovation and new business productivity while also investing to build growth for the future. $ECL's Institutional, Industrial and Other segments continue to deliver mid-single digit acquisition adjusted fixed currency sales growth.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.